Cancer Genetics (CGIX) Q4 2020 Earnings

31MarConfirmed
Jun 20
Sep 20
Dec 20
Q4 2020
-1.05
-0.75
-0.44
-0.14

Details

Expected EPS
N/A
Actual EPS
-0.14
Surprise EPS
-0.14
Surprise Percent
+∞%

Description

Cancer Genetics (CGIX) has reported earnings of -0.14 per share for Q4 2020.

0 Comments

Share your thoughts